| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Revenue | $28.1M | -10.9% |
| Cost of Revenue | $16.9M | -4.3% |
| Gross Profit | $11.1M | -19.5% |
| R&D Expense | $1.7M | -10.7% |
| SG&A Expense | $7.4M | +9.7% |
| Operating Income | -$2.5M | -393.6% |
| Pre-tax Income | -$2.3M | — |
| Income Tax | $573K | +920.5% |
| Net Income | -$2.9M | -5816.5% |
| EPS (Basic) | -$0.28 | -1300.0% |
| EPS (Diluted) | -$0.28 | -1300.0% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $6.1M | -29.4% |
| Inventory | $12.5M | -11.4% |
| Current Assets | $20.3M | -13.9% |
| Total Assets | $23.4M | -15.3% |
| Current Liabilities | $16.8M | +77.8% |
| Total Liabilities | $17.8M | -4.5% |
| Stockholders' Equity | $3.9M | -46.2% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.2M | +81.9% |
| Capital Expenditures | $792K | +36.0% |
| Investing Cash Flow | -$788K | +32.6% |
| Financing Cash Flow | -$667K | -213.0% |
| Free Cash Flow | $1.4M | +126.4% |